Capital Advisors Ltd’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

Capital Advisors Ltd’s Portfolio PTVE Stock Details PTVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-391	Closed	-$7K	–	1686
2025 Q1	$7K	Hold	391	–	–	﹤0.01%	870
2024 Q4	$7K	Hold	391	–	–	﹤0.01%	892
2024 Q3	$5K	Hold	391	–	–	﹤0.01%	943
2024 Q2	$4K	Hold	391	–	–	﹤0.01%	969
2024 Q1	$6K	Hold	391	–	–	﹤0.01%	860
2023 Q4	$5K	Buy	391 +4	+1%	+$42	﹤0.01%	863
2023 Q3	$3K	Hold	387	–	–	﹤0.01%	972
2023 Q2	$3K	Buy	+387	New	+$2.96K	﹤0.01%	979
2022 Q2	–	Sell	-133	Closed	-$1K	–	1387
2022 Q1	$1K	Buy	+133	New	+$1.41K	﹤0.01%	837

Capital Advisors Ltd's PTVE Position: Q2 2025 in Review

Capital Advisors Ltd sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q2 2025, closing a stake of 391 shares — an estimated $7K sold.

Capital Advisors Ltd first reported a position in PTVE in Q1 2022 and held it in 9 quarters. The position peaked at $7K in Q1 2025. 0 funds tracked by Wall St. Rank hold PTVE as of Q2 2025.

Capital Advisors Ltd reported no remaining Pactiv Evergreen Inc. Common stock position as of Q2 2025 after selling out during the quarter.
Capital Advisors Ltd sold 391 Pactiv Evergreen Inc. Common stock shares in Q2 2025, an estimated $7K.
Capital Advisors Ltd first reported a position in Pactiv Evergreen Inc. Common stock in Q1 2022 and held it in 9 quarters.
Capital Advisors Ltd's Pactiv Evergreen Inc. Common stock position peaked at $7K in Q1 2025.
0 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q2 2025.

Based on Capital Advisors Ltd's 13F filing for Q2 2025, filed 24 Jul 2025.